ICON
Also known as: GloboMax | GloboMax (ICON plc) | Healthcare Discoveries d/b/a ICON Development Solutions | ICON Bioscience Inc | ICON Cancer Care, Queensland, Australia | Icon Cancer Care South Brisbane | ICON Clinical Research | ICON Clinical Research Limited | ICON Clinical Research LLC | ICON Developmental Solutions | ICON Development Solutions | ICON Development Solutions, LLC | ICON Development Solutions Manchester, Manchester Science Park, Manchester, UK | ICON Development Solutions Manchester, UK | ICON Development Solutions, Manchester, UK | ICON Development Solutions UK | ICON Early Phase Service | ICON Early Phase Services | ICON Early Phase Services/CRU | ICON Early Phase Services, LLC | ICON Early Phase Services (Parts 1 & 2) | ICON GPHS | Icon, Inc. | ICON Manchester CPU | ICON plc | ICON plc, 8307 Gault Lane, San Antonio TX 78209
Highest phase reached
Phase 4
First clinical trial
Oct 1, 2002Last known activity
Nov 17, 2025
Timeline
1990s
- Jan 1, 1990
ICON— Founded
2000s
- Jan 24, 2003
Medeval Limited— Acquired
- Nov 14, 2008
Prevalere Life Sciences— Acquired
- Jan 8, 2009
Deacon Biosciences, Inc.— Acquired
- Jul 9, 2009
Veeda Laboratories— Acquired
2010s
- Dec 12, 2011
BeijingWits Medical Consulting Ltd— Acquired
- May 8, 2014
Aptiv Solutions— Acquired
- Dec 7, 2015
PMG Research— Acquired
- Sep 19, 2016
Clinical Research Management, Inc.— Acquired
- Jul 27, 2017
Mapi Pharma Ltd.— Acquired
- Jan 1, 2019
MolecularMD— Acquired - May 23, 2019
Medinova AG— Acquired
2020s
- Feb 23, 2021
Drugs by trial phase (366 distinct, 352 trials)
Phase 4 (3 own, 9 via acquisition)
Phase 3 (26 own, 57 via acquisition)
Phase 2 (50 own, 68 via acquisition)
Phase 1 (60 own, 92 via acquisition)
Other trials (0 own, 1 via acquisition)
Indications
Studied for
- Afibrinogenemia
- Alzheimer Disease
- Amenorrhea
- Amyotrophic Lateral Sclerosis
- Anemia
- Anemia, Iron-Deficiency
- Anus Neoplasms
- Arthritis
- Arthritis, Rheumatoid
- Basal Cell Carcinoma
- Brain Injuries
- Brain Injuries, Traumatic
- Breast Neoplasms
- Carcinoma
- Carcinoma, Neuroendocrine
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Squamous Cell
- Cardiovascular Diseases
- Cataract
- Cholangiocarcinoma
- Choroidal Neovascularization
- Chronic Pain
- Cicatrix
- Cognitive Dysfunction
- Colorectal Neoplasms
- Communicable Diseases
- Congenital Abnormalities
- Coronary Artery Disease
- Coronary Disease
- Crohn Disease
- Cystic Fibrosis
- Deficiency Diseases
- Dementia
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diabetic Neuropathies
- Digestive System Neoplasms
- Endometrial Neoplasms
- Epilepsy
- Esophagitis
- Fallopian Tube Neoplasms
- Fatty Liver
- Fibrosis
- Gastrointestinal Neoplasms
- Heart Failure
- Hemorrhagic Fever, Ebola
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hidradenitis
- Hidradenitis Suppurativa
- Histiocytoma, Malignant Fibrous
- Hypertension, Pulmonary
- Infections
- Inflammation
- Insulin Resistance
- Irritable Bowel Syndrome
- Kidney Diseases
- Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Leukemia, Myeloid, Chronic-Phase
- Lung Neoplasms
- Lupus Erythematosus, Systemic
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Follicular
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Non-Hodgkin
- Macular Degeneration
- Malaria
- Malaria, Falciparum
- Melanoma
- Mesothelioma
- Motor Neuron Disease
- Myelodysplastic Syndromes
- Myocardial Ischemia
- Nasopharyngeal Carcinoma
- Neoplasm Metastasis
- Neoplasms
- Neovascularization, Pathologic
- Neuroendocrine Tumors
- Neutropenia
- Non-alcoholic Fatty Liver Disease
- Osteogenesis Imperfecta
- Ovarian Neoplasms
- Pain
- Pancreatic Neoplasms
- Peripheral Nervous System Diseases
- Peritoneal Neoplasms
- Polyneuropathies
- Polyradiculoneuropathy
- Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
- Postoperative Pain
- Preleukemia
- Premature Birth
- Premature Ejaculation
Subsidiaries (12 direct, 26 total across the full acquisition tree)
- Aptiv Solutions
- BeijingWits Medical Consulting Ltd
- Clinical Research Management, Inc.
- Deacon Biosciences, Inc.
- Mapi Pharma Ltd.
- Medeval Limited
- Medinova AG
- MolecularMD
- Pharmaceutical Research Associates, Inc. (PRA)
- PMG Research
- Prevalere Life Sciences
- Veeda Laboratories
- ClinResearch, GmbH L2
- ClinStar, LLC L2
- CRI Worldwide L2
- Hespirion L2
- Millennix L2
- Nextrials, Inc. L2
- Parallel 6 L2
- Pharma Bio-Research Group B.V., Zuidlaren, The Netherlands L2
- Regulatory/Clinical Consultants L2
- ReSearch Pharmaceutical Services L2
- Sterling Synergy Systems L2
- Value Health Solutions L2
- ChapelPharma Ltd L3
- Lifetree Clinical Research L3
Recent trials (50)
- NCT07259330OfficialPhase 1Nov 17, 2025
- NCT07199569CollaboratorPhase 2Oct 27, 2025
- NCT07059000CollaboratorPhase 3Aug 13, 2025
- NCT07126262CollaboratorPhase 2Jul 30, 2025
- NCT07076030CollaboratorPhase 1Apr 15, 2025
- NCT06877624OfficialPhase 1Jan 10, 2025
- NCT06716606CollaboratorPhase 3Dec 4, 2024
- NCT06328608CollaboratorPhase 2/Phase 3Oct 31, 2024
- NCT06560151CollaboratorPhase 2Aug 21, 2024
- NCT06532396OfficialPhase 1Jul 1, 2024
- NCT06385509CollaboratorPhase 4May 10, 2024
- NCT06401213OfficialPhase 1Apr 15, 2024
- NCT06401213CollaboratorPhase 1Apr 15, 2024
- NCT06172257CollaboratorPhase 3Dec 31, 2023
- NCT05997264CollaboratorPhase 2Dec 5, 2023
Details
- Founded
- Dublin, IE Jan 1, 1990
- Last known activity
- Nov 17, 2025